A
s one of 30,000 oncology professionals attending the 51st American Society of Clinical Oncology (ASCO) meeting, I am excited about the future of cancer care but I’m also concerned. As a researcher, I welcome the opportunity for scientific exchange at what is the most important oncology research gathering of the year. But as a physician, I’m concerned that the current focus on costs will jeopardize future progress and access to life-enhancing therapies – or even cures – for the patients who need them.
